Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Massive registry launches to see how brain aneurysm devices perform in real life

NCT ID NCT07474935

Knowledge-focused Sponsor: Phenox GmbH Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This registry is following 5,000 people who receive WallabyPhenox flow diverters or other devices to treat brain aneurysms, dissections, or perforations. Researchers are tracking safety, performance, and patient outcomes over time in routine hospital practice. The goal is to gather real-world evidence on how well these devices work outside of controlled clinical trials.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Neurovascular flow diverter devices (p64, p48, and HPC variants)
What this could lead to
If successful, this registry will provide real-world data on how safe and effective these devices are for treating brain aneurysms and related conditions.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by differences in patient care across hospitals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 5,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Jan 2041

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The registry population comprising of patients suffering from cranial diseases as per indication of target registry devices (intracranial aneurysms, pseudo-aneurysms, neurovascular abnormalities, dissections, perforations, neurovascular abnormalities, and other indication), is deemed representative of the target population in terms of characteristics and standard care.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subject treated or intended to be treated with at least one target registry device during the procedure (i.e., at least one attempt of introduction into the vasculature of the subject), * Non-opposition to data collection or informed consent provided by the subject or legal representative as per country-specific legislation. Exclusion Criteria: * Participation in an interventional study modifying standard care management for all relevant indications,

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bifurcation aneurysms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Aneurysm Aneurysm, False brain aneurysm Constriction, Pathologic X-Linked Combined Immunodeficiency Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bifurcation aneurysms Intracranial aneurysms Neurovascular abnormalties Perforation Pseudoaneurysm Saccular and fusiform aneurysms Stenosis Vascular dissection Wide-neck aneurysm

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    13 sites in 5 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • ASST Grande Ospedale Metropolitano Niguarda, Milano

    NOT_YET_RECRUITING

    Milan, 20162, Italy

  • Antonio Cardarelli Hospital- Naples

    NOT_YET_RECRUITING

    Naples, 80131, Italy

  • CHU Brest - Hôpital de La Cavale Blanche

    RECRUITING

    Brest, 29200, France

  • Cannizzaro Hospital in Catania

    NOT_YET_RECRUITING

    Catania, 95126, Italy

  • Helios Klinikum Erfurt

    NOT_YET_RECRUITING

    Erfurt, 99089, Germany

  • Kantonsspital St.Gallen

    NOT_YET_RECRUITING

    Sankt Gallen, 9007, Switzerland

  • Klinikum Nürnberg

    NOT_YET_RECRUITING

    Nuremberg, 90471, Germany

  • LMU Klinikum

    NOT_YET_RECRUITING

    München, 81377, Germany

  • Pitié Salpêtrière Hospital

    NOT_YET_RECRUITING

    Paris, 75013, France

  • University Hospital Heidelberg

    NOT_YET_RECRUITING

    Heidelberg, 69120, Germany

  • Universitätsklinikum Hamburg-Eppendorf

    NOT_YET_RECRUITING

    Hamburg, 20246, Germany

  • Universitätsspital Basel

    NOT_YET_RECRUITING

    Basel, 4031, Switzerland

  • Univerzitná nemocnica L. Pasteura Košice

    RECRUITING

    Košice, 040 11, Slovakia

More trials for these conditions

Other studies related to the condition(s) this trial covers.